Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Disease”

343 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 343 results

Testing effectiveness (Phase 2)Looking for participantsNCT06419205
What this trial is testing

Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

Who this might be right for
IgA NephropathyLupus Nephritis (LN)C3 (Complement Component 3) Glomerulopathy
Akebia Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT03453619
What this trial is testing

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

Who this might be right for
IgA NephropathyLupus NephritisMembranous Nephropathy+2 more
Apellis Pharmaceuticals, Inc. 21
Not applicableEnded earlyNCT03607500
What this trial is testing

Effect of Moderate Caloric Restriction on Glomerular Growth After Kidney Transplantation

Who this might be right for
Kidney Transplant; ComplicationsGlomerular DiseaseWeight Gain+1 more
University of Michigan 1
Testing effectiveness (Phase 2)Study completedNCT01610492
What this trial is testing

Belimumab in Idiopathic Membranous Glomerulonephropathy

Who this might be right for
Glomerulonephritis, Membranous
GlaxoSmithKline 14
Not applicableNot Yet RecruitingNCT06691529
What this trial is testing

Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular Disease

Who this might be right for
Fatty Liver DiseaseChronic Glomerular Disease
Assiut University 500
Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Post-approval studies (Phase 4)Study completedNCT01744067
What this trial is testing

The Effects of Omega-3 Fatty Acids in Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Oslo University Hospital 132
Testing effectiveness (Phase 2)UnknownNCT02682459
What this trial is testing

ACE-inhibitors in Extracapillary Glomerulonephritis

Who this might be right for
Extracapillary Glomerulonephritis
Monia Lorini 22
Early research (Phase 1)Study completedNCT01484561
What this trial is testing

Evaluate The Effect Of CP-690,550 On Measures Of Kidney Function In Patients With Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 148
Not applicableLooking for participantsNCT07349797
What this trial is testing

MediBeacon® Transdermal GFR System for the Evaluation of Kidney Function in Adults With Heart Failure

Who this might be right for
Glomerular Filtration RateHeart Failure
MediBeacon 15
Not applicableStudy completedNCT04449172
What this trial is testing

ProtocoL for GFR Measurement Using Iohexol (SCOPE-PLUS) - A Substudy of the SCOPE Study

Who this might be right for
Chronic Kidney Diseases
Istituto Nazionale di Ricovero e Cura per Anziani 100
Not applicableStudy completedNCT02881034
What this trial is testing

Ribavirin Bioavailability After Telaprevir Exposure

Who this might be right for
Hepatitis C
Hospices Civils de Lyon 37
Not applicableStudy completedNCT03984071
What this trial is testing

The Predictive Value of eGFR for Adverse Cardiovascular Events in Patients With STEMI

Who this might be right for
ST Elevation Myocardial Infarction
Dongying Zhang 3
Testing effectiveness (Phase 2)Looking for participantsNCT04183101
What this trial is testing

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

Who this might be right for
C3 GlomerulopathyMembranoproliferative GlomerulonephritisComplement Abnormality+2 more
Region Skane 30
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06687174
What this trial is testing

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy (IgAN)
Wuhan Createrna Science and Technology Co., Ltd 72
Post-approval studies (Phase 4)UnknownNCT02646397
What this trial is testing

Benidipine and Hydrochlorothiazide in Fosinopril Treated Chronic Kidney Disease Patients With Hypertension

Who this might be right for
Chronic Kidney Disease
Shanghai Changzheng Hospital 508
Post-approval studies (Phase 4)Study completedNCT02344602
What this trial is testing

The Effect of Uric Acid Lowering in Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
University Health Network, Toronto 73
Not applicableStudy completedNCT01459770
What this trial is testing

Medication Intervention in Transitional Care to Optimize Outcomes & Costs for CKD & ESRD

Who this might be right for
Chronic Kidney DiseaseEnd-Stage Renal Disease
Providence Medical Research Center 120
Large-scale testing (Phase 3)Looking for participantsNCT04817618
What this trial is testing

Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.

Who this might be right for
C3G
Novartis Pharmaceuticals 98
Next Page